Active: new fund May 2026 Verified 4 Nov 2026
Newpath Partners
Boston multi-stage venture capital firm focused on life sciences and healthcare.
- Type
- VC firm
- Location
- Boston, Massachusetts, United States
- Sectors
- Biotech, Healthtech and life sciences
- Fund size / AUM
- $350M Newpath Partners II (Form D offering, 2021)
- Latest fund or filing
- 28 May 2026
- Website
- www.newpath.partners
Fund filings (SEC Form D)
- Latest fund on file
- Newpath Partners IV
- Filed
- 28 May 2026 (new notice)
- Fund size
- $300M (total offering)
- Fund vehicles filed in the last 12 months
- 1 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For Newpath Partners, the paid file holds: 1 named decision-maker with roles; firm contact email (domain checked).
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
- www.sec.gov/Archives/edgar/data/2129493/000101297526000487/
- adviserinfo.sec.gov/firm/summary/300064
- www.newpath.partners/
- www.sec.gov/Archives/edgar/data/1849494/000184949421000002/
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 9 lists
Biotech investors in Massachusetts (37)Healthtech investors in Massachusetts (58)Venture capital firms in Massachusetts (185)Biotech venture capital firms in the US (297)Biotech investors (484)Healthtech venture capital firms in the US (709)Healthtech investors (1,207)Active venture capital firms in the US (1,574)Venture capital firms in the US (2,975)